• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酸二酯酶-5抑制剂他达拉非对氯化钾诱导的离体人输尿管组织收缩的影响。

The effect of phosphodiesterase-5 inhibitor, tadalafil, on potassium chloride-induced contractions of isolated human ureteral tissue.

作者信息

Sakthivel M S, Prabha Ratna, Singh Onkar, Kekre Nitin S, Kumar Santosh

机构信息

Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India.

Consultant Urologist, Kalyani Kidney Care Centre, Erode, Tamil Nadu, India.

出版信息

Indian J Urol. 2018 Oct-Dec;34(4):287-291. doi: 10.4103/iju.IJU_107_18.

DOI:10.4103/iju.IJU_107_18
PMID:30337785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6174708/
Abstract

INTRODUCTION

Drugs causing ureteral relaxation are used for medical expulsive therapy (MET) for stones. We investigated the ability of tadalafil to cause relaxation of potassium chloride (KCl)-induced contractions of isolated human ureteral tissue.

MATERIALS AND METHODS

Eight grossly normal proximal ureteral tissues were collected from the radical and donor nephrectomy specimen. The standard organ bath protocol was followed. Ureteral contractions were induced with 80 mM KCl before and after exposure to tadalafil.

RESULTS

The median amplitude and frequency of KCl-induced contractions and the median area under the contractility curve (AUCC) after exposure to 20 μM tadalafil showed significant reductions compared to that of before exposure to tadalafil (7.87 cm, 3.79/min, and 2.98 cm, respectively, versus 9.37 cm, 4.48/min, and 4.50 cm, respectively; = 0,026, 0.008, and 0.008, respectively). After exposure to 40 μM tadalafil, the median amplitude and frequency of KCl-induced contractions and AUCC (4.50 cm, 2.56/min, and 0.92 cm, respectively) showed significant reductions compared to that of before exposure to tadalafil (7.62 cm, 3.88/min, and 3.32 cm, respectively; = 0.008, 0.016, and 0.008, respectively). However, reductions in the parameters after exposure to 20 μM and 40 μM tadalafil were similar ( = 0.065, 0.195, and 0.130, respectively, for median amplitude, frequency, and AUCC).

CONCLUSION

Tadalafil reduces KCl-induced contractions of isolated human ureteral tissue . No incremental relaxations in contractions occurred by increasing the dose of tadalafil from 20 μM to 40 μM.

摘要

引言

用于结石药物排石治疗(MET)的药物可使输尿管松弛。我们研究了他达拉非使氯化钾(KCl)诱导的离体人输尿管组织收缩松弛的能力。

材料与方法

从根治性肾切除术和供体肾切除术标本中收集8个大体正常的近端输尿管组织。遵循标准的器官浴方案。在暴露于他达拉非之前和之后,用80 mM KCl诱导输尿管收缩。

结果

与暴露于他达拉非之前相比,暴露于20 μM他达拉非后,KCl诱导收缩的中位幅度、频率以及收缩力曲线下的中位面积(AUCC)均显著降低(分别为7.87 cm、3.79次/分钟和2.98 cm,而之前分别为9.37 cm、4.48次/分钟和4.50 cm;P分别为0.026、0.008和0.008)。暴露于40 μM他达拉非后,KCl诱导收缩的中位幅度、频率和AUCC(分别为4.50 cm、2.56次/分钟和0.92 cm)与暴露于他达拉非之前相比显著降低(分别为7.62 cm、3.88次/分钟和3.32 cm;P分别为0.008、0.016和0.008)。然而,暴露于20 μM和40 μM他达拉非后参数的降低相似(中位幅度、频率和AUCC的P分别为0.065、0.195和0.130)。

结论

他达拉非可降低KCl诱导的离体人输尿管组织收缩。将他达拉非的剂量从20 μM增加到40 μM时,收缩的松弛程度没有增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/be66d872e12d/IJU-34-287-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/855b504eeb54/IJU-34-287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/26fbf5378c77/IJU-34-287-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/7e91d39d4a41/IJU-34-287-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/a6c1a1e947fd/IJU-34-287-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/54a0878457a0/IJU-34-287-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/be66d872e12d/IJU-34-287-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/855b504eeb54/IJU-34-287-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/26fbf5378c77/IJU-34-287-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/7e91d39d4a41/IJU-34-287-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/a6c1a1e947fd/IJU-34-287-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/54a0878457a0/IJU-34-287-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7b/6174708/be66d872e12d/IJU-34-287-g009.jpg

相似文献

1
The effect of phosphodiesterase-5 inhibitor, tadalafil, on potassium chloride-induced contractions of isolated human ureteral tissue.磷酸二酯酶-5抑制剂他达拉非对氯化钾诱导的离体人输尿管组织收缩的影响。
Indian J Urol. 2018 Oct-Dec;34(4):287-291. doi: 10.4103/iju.IJU_107_18.
2
In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.磷酸二酯酶5抑制剂西地那非、伐地那非和他达拉非对离体人输尿管平滑肌的体外作用:一项基础研究方法
Urol Res. 2007 Feb;35(1):49-54. doi: 10.1007/s00240-006-0073-1. Epub 2006 Nov 11.
3
Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones.他达拉非与α受体阻滞剂(阿夫唑嗪、多沙唑嗪、坦索罗辛和西洛多辛)作为<10毫米远端和近端输尿管结石的药物排石疗法。
Arch Ital Urol Androl. 2018 Jun 30;90(2):117-122. doi: 10.4081/aiua.2018.2.117.
4
Inhibition by tadalafil of contractility of isolated nonpregnant human myometrium.他达拉非对离体未孕人子宫肌层收缩性的抑制作用。
J Pharmacol Pharmacother. 2016 Oct-Dec;7(4):177-181. doi: 10.4103/0976-500X.195902.
5
Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005.磷酸二酯酶10选择性抑制剂TC-E 5005对人前列腺中肾上腺素能和非肾上腺素能平滑肌收缩的抑制作用。
Prostate. 2016 Nov;76(15):1364-74. doi: 10.1002/pros.23208. Epub 2016 Jul 15.
6
Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates.西洛多辛和他达拉非对人及大鼠前列腺组织的神经介导性收缩具有协同抑制作用。
Eur J Pharmacol. 2014 Dec 5;744:42-51. doi: 10.1016/j.ejphar.2014.09.030. Epub 2014 Sep 23.
7
Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.他达拉非增强坦索罗辛对人前列腺和膀胱颈部神经源性收缩的抑制作用。
J Sex Med. 2012 Sep;9(9):2293-306. doi: 10.1111/j.1743-6109.2012.02821.x. Epub 2012 Jul 3.
8
Tamsulosin versus tadalafil as a medical expulsive therapy for distal ureteral stones: A prospective randomized study.坦索罗辛与他达拉非作为治疗远端输尿管结石的医学排石疗法:一项前瞻性随机研究。
Investig Clin Urol. 2016 Sep;57(5):351-6. doi: 10.4111/icu.2016.57.5.351. Epub 2016 Sep 7.
9
The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics.选择性输尿管松弛剂KUL-7211对离体犬输尿管的效能:与多种解痉剂的比较
Urol Res. 2005 Dec;33(6):409-14. doi: 10.1007/s00240-005-0475-5. Epub 2005 Aug 25.
10
Efficacy of tamsulosin versus tadalafil as medical expulsive therapy on stone expulsion in patients with distal ureteral stones: A randomized double-blind clinical trial.坦索罗辛与他达拉非作为排石疗法治疗输尿管下段结石患者排石效果的比较:一项随机、双盲的临床试验。
Int Braz J Urol. 2021 Sep-Oct;47(5):982-988. doi: 10.1590/S1677-5538.IBJU.2020.1007.

引用本文的文献

1
Comparing efficacy and safety of monotherapy and combination therapy with tadalafil, tamsulosin, and silodosin for distal ureteral stones: A systematic review and meta-analysis.他达拉非、坦索罗辛和西洛多辛单药治疗与联合治疗远端输尿管结石的疗效和安全性比较:一项系统评价和荟萃分析。
Asian J Urol. 2025 Apr;12(2):189-203. doi: 10.1016/j.ajur.2024.05.003. Epub 2024 Sep 19.
2
What's inside.里面有什么。
Indian J Urol. 2018 Oct-Dec;34(4):239-240. doi: 10.4103/iju.IJU_294_18.

本文引用的文献

1
Tamsulosin versus tadalafil as a medical expulsive therapy for distal ureteral stones: A prospective randomized study.坦索罗辛与他达拉非作为治疗远端输尿管结石的医学排石疗法:一项前瞻性随机研究。
Investig Clin Urol. 2016 Sep;57(5):351-6. doi: 10.4111/icu.2016.57.5.351. Epub 2016 Sep 7.
2
Comparative efficacy of tadalafil versus tamsulosin as the medical expulsive therapy in lower ureteric stone: a prospective randomized trial.他达拉非与坦索罗辛作为输尿管下段结石药物排石疗法的疗效比较:一项前瞻性随机试验。
Cent European J Urol. 2016;69(2):178-82. doi: 10.5173/ceju.2016.766. Epub 2016 Jun 20.
3
Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial.
成人输尿管绞痛的医学排石治疗:一项多中心、随机、安慰剂对照试验。
Lancet. 2015 Jul 25;386(9991):341-9. doi: 10.1016/S0140-6736(15)60933-3. Epub 2015 May 18.
4
Tamsulosin versus tamsulosin plus tadalafil as medical expulsive therapy for lower ureteric stones: a randomized controlled trial.坦索罗辛与坦索罗辛联合他达拉非作为输尿管下段结石药物排石治疗的随机对照试验
Int J Urol. 2014 Oct;21(10):1012-5. doi: 10.1111/iju.12496. Epub 2014 Jun 3.
5
Direct effects of vardenafil on the ureter: in vitro investigation and potential clinical applications of intralumenal administration.伐地那非对输尿管的直接作用:腔内给药的体外研究及潜在临床应用。
J Endourol. 2013 Nov;27(11):1400-4. doi: 10.1089/end.2012.0612. Epub 2013 Aug 9.
6
Phosphodiesterase inhibitors in clinical urology.磷酸二酯酶抑制剂在临床泌尿科中的应用。
Expert Rev Clin Pharmacol. 2013 May;6(3):323-32. doi: 10.1586/ecp.13.16.
7
PDE5 inhibitors in non-urological conditions.PDE5 抑制剂在非泌尿科疾病中的应用。
Curr Pharm Des. 2009;15(30):3521-39. doi: 10.2174/138161209789206980.
8
Molecular mechanisms that could contribute to prolonged effectiveness of PDE5 inhibitors to improve erectile function.可能有助于磷酸二酯酶5抑制剂延长改善勃起功能疗效的分子机制。
Int J Impot Res. 2008 Jul-Aug;20(4):333-42. doi: 10.1038/ijir.2008.4. Epub 2008 Apr 17.
9
[PDE5 inhibitors. A new option in the treatment of ureteral colic?].[磷酸二酯酶5抑制剂。治疗输尿管绞痛的新选择?]
Urologe A. 2007 Sep;46(9):1219-23. doi: 10.1007/s00120-007-1409-3.
10
In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.磷酸二酯酶5抑制剂西地那非、伐地那非和他达拉非对离体人输尿管平滑肌的体外作用:一项基础研究方法
Urol Res. 2007 Feb;35(1):49-54. doi: 10.1007/s00240-006-0073-1. Epub 2006 Nov 11.